Reported Earlier, Select Medical Prices Subsidiary Concentra Group Initial Public Offering Of 22.5M Common Shares At $23.50/Share

7/25/24 3:11:35 AM ET

Hospital/Nursing Management

Health Care

Get the next $SEM alert in real time by email

In addition, Concentra has granted the underwriters a 30-day option to purchase up to an additional 3,375,000 shares of its common stock to cover over-allotments, if any. Concentra's common stock has been approved for listing on the New York Stock Exchange under the symbol "CON" and is expected to begin trading on July 25, 2024. The IPO is expected to close on July 26, 2024, subject to the satisfaction or waiver of customary closing conditions.

After the completion of the IPO, Select Medical will own 104,093,503 shares of Concentra's common stock, representing 82.23% of the total outstanding shares of Concentra's common stock (or 80.09% if the underwriters exercise in full their over-allotment option).

Get the next $SEM alert in real time by email

Date	Price Target	Rating	Analyst
8/20/2024	$42.00	Buy	BofA Securities
3/7/2022	$47.00 → $42.00	Outperform	RBC Capital
1/18/2022	$40.00 → $35.00	Buy	B of A Securities
1/18/2022	$50.00 → $47.00	Outperform	RBC Capital
8/10/2021	$37.00 → $39.00	Neutral	Credit Suisse

Reported Earlier, Select Medical Prices Subsidiary Concentra Group Initial Public Offering Of 22.5M Common Shares At $23.50/Share

Chat with this insight

Recent Analyst Ratings for $SEM

$SEM Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

EXECUTIVE VICE PRESIDENT Tarvin Michael E covered exercise/tax liability with 28,282 shares, decreasing direct ownership by 6% to 436,794 units (SEC Form 4)

CO-PRESIDENT Mullin Thomas P covered exercise/tax liability with 36,742 shares, decreasing direct ownership by 10% to 313,754 units (SEC Form 4)

Chief Information Officer Rusignuolo Brian R. covered exercise/tax liability with 25,690 shares, decreasing direct ownership by 8% to 301,050 units (SEC Form 4)

$SEM Leadership Updates

Live Leadership Updates

Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

Select Medical Holdings Corporation Announces Appointment of Parvinderjit Singh Khanuja, M.D. to its Board of Directors

Select Medical Holdings Corporation Announces Appointment of Katherine Davisson to its Board of Directors

$SEM Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Select Medical Holdings Corporation

Amendment: SEC Form SC 13G/A filed by Select Medical Holdings Corporation

Amendment: SEC Form SC 13G/A filed by Select Medical Holdings Corporation

$SEM Press Releases

Fastest customizable press release news feed in the world

Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

Select Medical Holdings Corporation Announces Distribution Ratio for Special Stock Distribution to Stockholders

Select Medical Holdings Corporation Announces Pricing of Offering of 6.250% Senior Notes due 2032 by Select Medical Corporation

$SEM Market Insights

Live Market Insights

$SEM Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

$SEM SEC Filings

Reported Earlier, Select Medical Prices Subsidiary Concentra Group Initial Public Offering Of 22.5M Common Shares At $23.50/Share

A Glimpse Into The Expert Outlook On Select Medical Hldgs Through 4 Analysts

Benchmark Maintains Buy on Select Medical Hldgs, Raises Price Target to $48

BofA Securities resumed coverage on Select Medical with a new price target

RBC Capital reiterated coverage on Select Medical Holdings with a new price target

B of A Securities reiterated coverage on Select Medical Holdings with a new price target

Select Medical Holdings Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

Select Medical Holdings Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

Select Medical Holdings Corporation filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

$SEM Financials

Live finance-specific insights

Select Medical Holdings Corporation to Announce Third Quarter 2024 Results on Thursday, October 31, 2024

Select Medical Holdings Corporation Announces Estimate of Certain Financial Results of its Wholly-Owned Subsidiary Concentra Group Holdings Parent, Inc. for the Second Quarter Ended June 30, 2024

Select Medical Holdings Corporation to Announce Second Quarter 2024 Results on Thursday, August 1, 2024

Recent Analyst Ratings for
$SEM

$SEM
Insider Trading

$SEM
Leadership Updates

$SEM
Large Ownership Changes

$SEM
Press Releases

$SEM
Market Insights

$SEM
Analyst Ratings

$SEM
SEC Filings

$SEM
Financials